{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:53Z","timestamp":1759334693318,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.arcmed.2005.06.013","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T14:37:51Z","timestamp":1141223871000},"page":"365-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Co-Infection by the Human T-Cell Lymphotropic Virus Type II in Patients Infected by the Human Immunodeficiency Virus in Yucatan, Mexico"],"prefix":"10.1016","volume":"37","author":[{"given":"Carlos Jos\u00e9","family":"Castro-Sansores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Santos-Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Gonz\u00e1lez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora M.","family":"Lara-Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Alonso-Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan A.","family":"Gongora-Biachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2005.06.013_bib1","series-title":"Clinical Virology Manual","first-page":"421","article-title":"Human retrovirus","author":"Schupbach","year":"1986"},{"key":"10.1016\/j.arcmed.2005.06.013_bib2","first-page":"440","article-title":"Human T-cell leukemia\/lymphoma viruses: life cycle, pathogenicity, epidemiology and diagnosis","volume":"115","author":"Hjelle","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.arcmed.2005.06.013_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(94)90994-6","article-title":"Human T-lymphotropic virus type I in Japan","volume":"343","author":"Yamaguchi","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2005.06.013_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1537-2995.1991.31191096189.x","article-title":"The epidemiology of human T-cell lymphotropic virus type I and type II: etiologic role in human disease","volume":"31","author":"Manns","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.arcmed.2005.06.013_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.41.1.85","article-title":"Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II","volume":"41","author":"Berger","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2005.06.013_bib6","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1073\/pnas.88.7.2922","article-title":"Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue syndrome immune dysfunction syndrome","volume":"88","author":"DeFreitas","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2005.06.013_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jmv.1890450407","article-title":"Presence of human T-lymphotropic virus type II-related genes in DNA of peripheral leucocytes from patients with autoimmune thyroid disease","volume":"45","author":"Yokoi","year":"1995","journal-title":"J Med Virol"},{"key":"10.1016\/j.arcmed.2005.06.013_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/rmv.1980030304","article-title":"The epidemiology of human T-lymphotropic virus types I and II","volume":"3","author":"Kaplan","year":"1993","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.arcmed.2005.06.013_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/170.1.206","article-title":"Transmission of human T-lymphotropic virus (HTLV) type II by transfusion of HTLV-I screened blood products","volume":"170","author":"Rios","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/infdis\/168.3.586","article-title":"Evidence for mother-to-child transmission of human T lymphotropic virus type II","volume":"168","author":"Lal","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0036-46651997000400006","article-title":"Prevalence of HTLV-I and HTLV-II infections among HIV-1 infected asymptomatic individuals in Sao Paulo, Brazil","volume":"39","author":"Casseb","year":"1997","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.arcmed.2005.06.013_bib12","first-page":"1228","article-title":"HTLV-II\/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users","volume":"6","author":"Visconti","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.arcmed.2005.06.013_bib13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0140-6736(90)91456-K","article-title":"HTLV-I\/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users","volume":"335","author":"Page","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2005.06.013_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.1994.03510290035033","article-title":"Coinfection with human T cell lymphotropic virus type I and HIV in Brazil","volume":"271","author":"Schechter","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2005.06.013_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00042560-199701010-00011","article-title":"Retroviral coinfection at a New Orleans HIV outpatient clinic","volume":"14","author":"Bessinger","year":"1997","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.arcmed.2005.06.013_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00042560-199804150-00002","article-title":"HTLV- I and HTLV-II virus expression increase with HIV-1 coinfection","volume":"17","author":"Beilke","year":"1998","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.arcmed.2005.06.013_bib17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.187.10.1689","article-title":"Factors secreted by human T lymphotropic virus type I (HTLV-I) infected cells can enhance or inhibit replication of HIV-1 in HTLV-I uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1","volume":"187","author":"Moriuchi","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2005.06.013_bib18","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.4049\/jimmunol.165.7.4127","article-title":"Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus Type II (HTLV-II) alone and HTLV-II\/HIV-1 coinfected individuals","volume":"165","author":"Lewis","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2005.06.013_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/infdis\/172.6.1595","article-title":"High prevalence of human T cell lymphotropic virus type II infection in patients affected by immunodeficiency virus type 1-associated predominantly sensory polyneuropathy","volume":"172","author":"Zehender","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib20","first-page":"104","article-title":"A low prevalence of HTLV-I\/II infection among eight population groups from Merida, Yucatan, Mexico","volume":"5","author":"Gongora-Biachi","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.arcmed.2005.06.013_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00000441-199310000-00001","article-title":"Human T lymphotropic virus type II (HTLV-II) infection among female prostitutes in Yucatan, Mexico","volume":"306","author":"Gongora-Biachi","year":"1993","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.arcmed.2005.06.013_bib22","first-page":"RR17","article-title":"1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Center for Diseases Control","year":"1992","journal-title":"MMWR"},{"key":"10.1016\/j.arcmed.2005.06.013_bib23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1537-2995.1993.331194082384.x","article-title":"Simultaneous confirmation and differentiation of human T lymphotropic virus type I and II infection by using recombinant proteins comprising immunodominant epitopes","volume":"33","author":"Brodine","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.arcmed.2005.06.013_bib24","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1097\/00042560-199600001-00034","article-title":"What is the situation of human T cell lymphotropic virus type II (HTLV-II) in Africa? Origin and dissemination of genomic subtypes","volume":"13","author":"Gessain","year":"1996","journal-title":"J Acquir Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.arcmed.2005.06.013_bib25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/165.5.920","article-title":"Infection with human T lymphotropic viruses types I and II in sexually transmitted disease clinics in Baltimore and New Orleans","volume":"165","author":"Wiktor","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/infdis\/172.1.51","article-title":"Seroprevalence of human T cell lymphotropic virus type II infection with or without human immunodeficiency deficiency virus type I coinfection among intravenous drug users","volume":"172","author":"Briggs","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib27","first-page":"555","article-title":"Low prevalence of HTLV-II in Mayan Indians in the Yucatan Peninsula, Mexico","volume":"28","author":"Gongora-Biachi","year":"1997","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2005.06.013_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/infdis\/166.5.1160","article-title":"Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations","volume":"166","author":"Buckner","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood.V80.2.544.544","article-title":"Failure to detect evidence of human T-lymphotropic virus type I and type II in blood donors with isolated gag reactivities","volume":"80","author":"Lal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2005.06.013_bib30","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.169.8.4443","article-title":"Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1","volume":"169","author":"Bovolenta","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2005.06.013_bib31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198904133201507","article-title":"HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus","volume":"320","author":"Wiley","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2005.06.013_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/WNL.41.2_Part_1.197","article-title":"The role of HTLV in HIV-1 neurologic disease","volume":"41","author":"Berger","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2005.06.013_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/infdis\/175.2.438","article-title":"Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo","volume":"175","author":"Harrison","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.06.013_bib34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00002030-200107060-00012","article-title":"Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA","volume":"6","author":"Goedert","year":"2001","journal-title":"AIDS"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905002857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905002857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:31:28Z","timestamp":1759260688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440905002857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0188440905002857"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.06.013","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-Infection by the Human T-Cell Lymphotropic Virus Type II in Patients Infected by the Human Immunodeficiency Virus in Yucatan, Mexico","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}